<DOC>
	<DOCNO>NCT02874209</DOCNO>
	<brief_summary>Amyotrophic lateral sclerosis ( ALS ) neurodegenerative disease affect central peripheral motor neuron , characterize rapidity evolution ( median survival 3 year ) . The pathophysiology disease still poorly understood . Neuronal death result several cellular mechanism entangle , include mitochondrial dysfunction . The absence diagnostic marker cause significant delay diagnosis , average year . On hand , wish biomarker important therapeutic trial . Recently , MRI sodium ( 23Na ) demonstrate importance detect noninvasively sodium accumulation associate neuronal suffering . This neuronal pain cause mitochondrial dysfunction cause accumulation sodium calcium cell cause neuronal death . These study conduct multiple sclerosis , Alzheimer 's disease , Huntington 's disease , stroke brain tumor . They demonstrate sodium MRI could effective sensitive biomarker detect quantify neuronal degeneration . The goal study assess neuronal damage noninvasively MRI sodium amyotrophic lateral sclerosis .</brief_summary>
	<brief_title>Noninvasive Assessment Neuronal Damage MRI Sodium ( 23Na ) Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Amyotrophic lateral sclerosis patient accord El Escorial criterion revise Brooks et al . 2000 bulbar spinal beginning patient healthy volonteer present MRI contre indication exam . patient healthy volonteer present severe high blood pressure undergo medication treat . patient healthy volonteer chronic psychiatric illness , dementia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>